logo
logo
Sign in

Heart Defect Closure Device Market

avatar
Apurva Phulari
Heart Defect Closure Device Market



The global heart defect closure device market is projected to witness a lucrative growth rate over the forecast period. This growth is attributed to the rising prevalence of congenital heart defects, technological advancements in cardiac devices, and the increasing demand for minimally invasive procedures.


Cardiac device market


The global heart defect closure device market is segmented into product type, application, end user, and region. On the basis of product type, the market is segmented into occluders, septal closure devices, and other products. Occluders are further segmented into transcatheter occluders, transcutaneous occluders, and others. On the basis of application, the market is segmented into atrial septal defect, ventricular septal defect, patent ductus arteriosus, and others. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and others.


Cardiac surgery devices


Cardiac surgery devices are used to treat heart diseases and disorders. These devices include stents, catheters, pacemakers, and others. Cardiac stents are devices that are inserted into the arteries in order to keep them open and unblocked. Pacemakers are implantable devices that are used to regulate the heart rhythm. Catheters are thin tubes used to access the heart and other organs.


The global heart defect closure device market is highly competitive in nature. The key players operating in the market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Johnson & Johnson, Edwards Lifesciences Corporation, and others. These players are focusing on technological advancements in their products, strategic collaborations, and other initiatives to gain a competitive edge in the market.


Heart Defect Closure Device Market


The rising prevalence of congenital heart defects is one of the major factors driving the growth of the heart defect closure device market. According to the Centers for Disease Control and Prevention, about 40,000 babies are born with a heart defect in the U.S. every year. This rising prevalence is expected to propel the demand for cardiac devices, thereby driving the growth of the heart defect closure device market.


Technological advancements in cardiac devices are also driving the growth of the heart defect closure device market. The introduction of minimally invasive procedures such as transcatheter closure of atrial septal defects and ventricular septal defects is expected to drive the market growth. The growing demand for minimally invasive procedures is expected to propel the demand for cardiac devices, which in turn is expected to drive the growth of the heart defect closure device market.


The increasing demand for cardiac devices in emerging markets such as India, China, and Brazil is expected to further drive the growth of the heart defect closure device market. The governments in these countries are introducing various initiatives to promote the use of medical devices. This is expected to create lucrative opportunities for the growth of the heart defect closure device market.


In conclusion, the global heart defect closure device market is expected to witness significant growth over the forecast period, owing to the rising prevalence of congenital heart defects, technological advancements in cardiac devices, and the increasing demand for minimally invasive procedures.

collect
0
avatar
Apurva Phulari
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more